Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

00:03 EDT 27th April 2015 | BioPortfolio

PubMed Articles [261 Associated PubMed Articles listed on BioPortfolio]

Correction: A Genome-Wide Association Study for Diabetic Retinopathy in a Japanese Population: Potential Association with a Long Intergenic Non-Coding RNA.

[This corrects the article DOI: 10.1371/journal.pone.0111715.].

Blue Cone Monochromacy: Visual Function and Efficacy Outcome Measures for Clinical Trials.

Blue Cone Monochromacy (BCM) is an X-linked retinopathy caused by mutations in the OPN1LW / OPN1MW gene cluster, encoding long (L)- and middle (M)-wavelength sensitive cone opsins. Recent evidence sho...

Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.

Type 1 diabetes (T1D) is an autoimmune disease with chronic hyperglycemic state, which incidence has been globally rising during the past decades. Besides the well-known diabetic complications such as...

Temporal Macular Dimple in Retinopathy of Prematurity.

Leukemic Retinopathy.

Nephropathy, but not Angiographically Proven Retinopathy, is Associated with Neutrophil to Lymphocyte Ratio in Patients with Type 2 Diabetes.

Background: Type 2 Diabetes Mellitus is a leading cause of end stage renal disease in the worldwide. Inflammation is regarded as one of the main reasons for the progression of diabetes complications. ...

Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria.

Corneal innervation is increasingly used as a surrogate marker of human diabetic peripheral neuropathy (DPN) however its temporal relationship with the other microvascular complications of diabetes is...

A Five-Year Prospective Study of Diabetic Retinopathy Progression in Chinese Type 2 Diabetes Patients with "Well-Controlled" Blood Glucose.

To determine the progression rate and risk factors for diabetic retinopathy (DR) in Chinese type 2 diabetic patients who have reached the target hemoglobin A1c (HbA1c) level recommended by the America...

The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010.

To explore the relationship between chronic kidney disease and diabetic retinopathy in a representative population of Korean diabetic adults.

Cerebral microvascular pericytes and Neurogliovascular signaling in health and disease.

Increases in neuronal activity cause an enhanced blood flow to the active brain area. This neurovascular coupling is regulated by multiple mechanisms: Adenosine and lactate produced as metabolic end-p...

News Articles [135 Associated News Articles listed on BioPortfolio]

Rise in Spring Allergens Linked to Increased Dry Eye Cases

SAN FRANCISCO, April 23, 2015 /PRNewswire/ -- New ophthalmology research from the University of Miami shows that dry eye – the little understood culprit behind red, watery, gritty feeling eyes &...

Welch Allyn partners with LKC to distribute RETeva device outside US

LKC Technologies has partnered with Welch Allyn for RETeval – DR device, which has been developed to evaluate people with diabetes for sight threatening diabetic retinopathy (DR).

RETeval™ Expands Presence at ARVO to Include Testing for Acquired and Inherited Diseases of the Retina

GAITHERSBURG, Md., April 22, 2015 /PRNewswire/ -- RETeval - DR™, a Welch Allyn device manufactured by LKC Technologies, Inc., is exclusively available outside of the United States through Welch ...

Retinal Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

LONDON, April 22, 2015 /PRNewswire/ -- This report on the retinal surgery devices market studies the current as well as future prospects of the market globally. Retinal surgery devices are rapidly gai...

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-03-18. This 54-page r...

Clarity Medical’s RetCam Will Be Used in a Worldwide Clinical Study for the Treatment of Premature Infant Ocular Disease

Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image...

Fundus Cameras Market Expected to Reach USD 300.5 Million Globally in 2019: Transparency Market Research

Transparency Market Research announces the release of a new report titled “Fundus Cameras Market (Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hosp...

Eyenuk receives CE mark approval for EyeArt software

US-based Eyenuk has received CE mark approval for its EyeArt software, a suite of image analysis tools for automated high-throughput screening of diabetic retinopathy.

Eyenuk, Inc. Granted CE Marking For EyeArt™ Automated High-Throughput Diabetic Retinopathy Screening

LOS ANGELES, April 14, 2015 /PRNewswire/ -- Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced image analysis tools for automat...

Global Ophthalmic Devices Market Will Grow $2,685.1 Million in 2020, by Persistence Market Research

New York, NY, April 11, 2015 --(PR.com)-- According to a new market report published by Persistence Market Research “Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by...

Events [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [175 Associated Clinical Trials listed on BioPortfolio]

Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

The primary objective of the study is to explore the effect of REGN2176-3 on the Early Treatment Diabetic Retinopathy Scale (ETDRS) best-corrected visual acuity (BCVA) in patients with neo...

Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

The primary objective of the protocol is to determine if visual acuity outcomes at 2 years in eyes with proliferative diabetic retinopathy (PDR) that receive anti-vascular endothelial grow...

Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy

This study was conducted to investigate the levels of angiogenic factors and anti-angiogenic factors in the aqueous humor of patients with diabetic retinopathy.

TES for the Treatment of RP

Retinitis pigmentosa (RP) is a progressive degenerative disease of the retina, which often leads to blindness. 1 in 4000 people in the UK are affected by RP yet there is no established the...

Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography

The main objective of this observational study is to characterize and correlate functional and structural changes at the retinal level using the Retinal Leakage Analyzer (RLA) and the Opti...

Family Myopia Study

This study will try to identify the gene or genes responsible for myopia (nearsightedness) and to examine the relationship between myopia and near work. Myopia is the most common eye disor...

Retinal Thickness Analysis Using Optical Coherence Tomography

The main objective of this study is to characterize and correlate diabetic macular edema (DME), i.e. increased retinal thickness, measured by Optical Coherence Tomograph (OCT), and retinal...

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

This study is to see whether treating diabetic retinal swelling with ranibizumab injections into the eye monthly is better than treating diabetic retinal swelling with ranibizumab injectio...

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment

This study evaluates a new investigational treatment regimen of three consecutive monthly doses of ranibizumab followed by an as-needed treatment regimen, with monthly follow-up for the fi...

Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)

To characterise phenotypes of Non Proliferative Diabetic Retinopathy (NPDR) progression using multimodal testing/imaging procedures.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks